James J. Collins
Direktor/Vorstandsmitglied bei Enable Injections, Inc.
Profil
James J.
Collins is currently the Director at Enable Injections, Inc. and an Advisor at The Innovation Factory LLC.
He graduated with an undergraduate degree from the United States Naval Academy in 1984 and earned an MBA from J.
Mack Robinson College of Business.
Aktive Positionen von James J. Collins
| Unternehmen | Position | Beginn |
|---|---|---|
The Innovation Factory LLC
 The Innovation Factory LLC Investment ManagersFinance The Innovation Factory LLC (The Innovation Factory) is an incubator firm headquartered in Duluth, Georgia. The firm is founded by Thomas D. Weldon and Charles E. Larsen in 1999. | Private Equity Investor | - |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Direktor/Vorstandsmitglied | 31.05.2022 |
Ausbildung von James J. Collins
| United States Naval Academy | Undergraduate Degree |
| J. Mack Robinson College of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
The Innovation Factory LLC
The Innovation Factory LLC Investment ManagersFinance The Innovation Factory LLC (The Innovation Factory) is an incubator firm headquartered in Duluth, Georgia. The firm is founded by Thomas D. Weldon and Charles E. Larsen in 1999. | Finance |
Enable Injections, Inc.
Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Health Technology |